Iterum Therapeutics plc (ITRMF) Accumulated Depreciation (2017 - 2025)

Iterum Therapeutics has reported Accumulated Depreciation for 9 years, with the latest figure at $91000.0 in Q3 2025.

• On a quarterly basis, Accumulated Depreciation fell 72.67% year-over-year to $91000.0 in Q3 2025; TTM through Sep 2025 was $91000.0, a 72.67% decrease from a year earlier, with the FY2024 full-year figure at $340000.0, up 7.94% from the prior year.
• Accumulated Depreciation was $91000.0 for Q3 2025 at Iterum Therapeutics, down from $308000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation was $845000.0 in Q3 2021, with the low at $91000.0 in Q3 2025.
• Average Accumulated Depreciation over 5 years is $356631.6, with a median of $308000.0 recorded in 2025.
• The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation jumped 77.89% in 2021, then sank 72.67% in 2025.
• Over 5 years, Accumulated Depreciation stood at $286000.0 in 2021, then dropped by 0.7% to $284000.0 in 2022, then increased by 10.92% to $315000.0 in 2023, then advanced by 7.94% to $340000.0 in 2024, then plunged by 73.24% to $91000.0 in 2025.
• The last three Accumulated Depreciation figures came in at $91000.0 (Q3 2025), $308000.0 (Q2 2025), and $302000.0 (Q1 2025), per Business Quant data.